ARCH Venture Management, LLC: 13F holdings
CIK 12744032026Q2
| Positions | 12 |
|---|
| Reported value | $1.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 12 (+2 vs prior quarter) |
|---|
| Reported value | $1.1bn (+62.5%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| PBLS PARABILIS MEDICINES INC | 6,412,780 | $175.5m | 16.0% |
| BEAM BEAM THERAPEUTICS INC | 4,540,132 | $155.8m | 14.2% |
| RAPP RAPPORT THERAPEUTICS INC | 3,728,738 | $155.4m | 14.1% |
| SEAPORT THERAPEUTICS INC | 6,294,951 | $136.6m | 12.4% |
| ERAS ERASCA INC | 7,091,557 | $129.9m | 11.8% |
| VIR VIR BIOTECHNOLOGY INC | 12,694,163 | $129.4m | 11.8% |
| MAZE MAZE THERAPEUTICS INC | 4,120,053 | $123.0m | 11.2% |
| LYELL IMMUNOPHARMA INC | 3,247,162 | $45.5m | 4.1% |
| GENB GENERATE BIOMEDICINES INC | 1,944,426 | $32.8m | 3.0% |
| TXG 10X GENOMICS INC | 217,834 | $8.4m | 0.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1274403")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples